Back to Search
ANTHONY NIGRO, MD
MD
Physical Medicine & Rehabilitation Physician
NPI: 1639923386Individual
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
4351052344(MI)
Research & Publications (20)
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.
PMID 19208566·J Rheumatol·2009
8-other
Inclusive K(S);(0)K(S);(0) resonance production in ep collisions at HERA.
PMID 18851276·Phys Rev Lett·2008
8-other
Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization.
PMID 18583466·J Clin Endocrinol Metab·2008
8-other
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
PMID 18240181·Arthritis Rheum·2008
5-case
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors.
PMID 17983756·Bioorg Med Chem·2008
7-preclinical
Plasma protein Z and protein C inhibitors and their role in hypercoagulability of thalassemia.
PMID 17804900·Acta Haematol·2007
3-trial
The immunomodulatory protein SV-IV protects serum-deprived cells against apoptosis but not against G0/G1 arrest: possible implications for the survival of implanting embryo.
PMID 17458892·J Cell Physiol·2007
7-preclinical
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.
PMID 17362524·Retrovirology·2007
6-review
1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors.
PMID 17127062·Bioorg Med Chem Lett·2007
7-preclinical
Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician.
PMID 16706966·J Thromb Haemost·2006
8-other
3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agent.
PMID 16504501·Bioorg Med Chem Lett·2006
8-other
Management of liver disease in thalassemia: main drug targets for a correct therapy.
PMID 16375691·Curr Drug Targets Immune Endocr Metabol Disord·2005
6-review
[Etanercept in the treatment of rheumatoid arthritis. A case report].
PMID 15932034·Recenti Prog Med·2005
5-case
Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs).
PMID 15745819·Bioorg Med Chem Lett·2005
7-preclinical
[Prevention and treatment of congenital toxoplasmosis: organization protocol].
PMID 15258548·Minerva Ginecol·2004
8-other
Regio- and stereospecific syntheses of syn- and anti-1,2-imidazolylpropylamines from the reaction of 1,1'-carbonyldiimidazole with syn- and anti-1,2-amino alcohols.
PMID 15255749·J Org Chem·2004
8-other
Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.
PMID 15177565·Genomics·2004
7-preclinical
Conservative management of a large subcapsular hematoma of the spleen in a child with severe hemophilia.
PMID 14608209·J Pediatr Hematol Oncol·2003
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3601 W 13 MILE RD
ROYAL OAK, MI 48073 - Phone
- (248) 898-5000
Quick Facts
- NPI
- 1639923386
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile